All Stories

  1. Venetoclax in the treatment of chronic lymphocytic leukemia

    Article • Expert Opinion on Drug Metabolism & Toxicology, April 2019, Taylor & Francis

    Anna Korycka-Wolowiec, Aleksandra Kubiak-Mlonka, Tadeusz Robak

  2. Bendamustine alone or with rituximab modifies expression of apoptosis-regulating genes and proteins of CLL cells, depending on IGVH mutational status

    Article • Leukemia & Lymphoma, September 2018, Taylor & Francis

    Anna Korycka-Wolowiec, Ewa Balcerczak, Tadeusz Robak

  3. Clonal evolution in CLL patients as detected by FISH versus chromosome banding analysis, and its clinical significance

    Article • European Journal Of Haematology, December 2013, Wiley

    Anna Korycka-Wolowiec